| Year |
Citation |
Score |
| 2000 |
Simkin GO, Tao JS, Levy JG, Hunt DW. IL-10 contributes to the inhibition of contact hypersensitivity in mice treated with photodynamic therapy. Journal of Immunology (Baltimore, Md. : 1950). 164: 2457-62. PMID 10679082 DOI: 10.4049/Jimmunol.164.5.2457 |
0.327 |
|
| 2000 |
Honey CR, Obochi MO, Shen H, Margaron P, Yip S, Levy JG. Reduced xenograft rejection in rat striatum after pretransplant photodynamic therapy of murine neural xenografts. Journal of Neurosurgery. 92: 127-31. PMID 10616091 DOI: 10.3171/Jns.2000.92.1.0127 |
0.321 |
|
| 2000 |
Granville DJ, Carthy CM, Jiang H, Levy JG, McManus BM, Matroule J, Piette J, Hunt DWC. Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin Blood. 95: 256-262. DOI: 10.1182/Blood.V95.1.256.001K29_256_262 |
0.339 |
|
| 1999 |
Granville DJ, Jiang H, An MT, Levy JG, McManus BM, Hunt DW. Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy. British Journal of Cancer. 79: 95-100. PMID 10408699 DOI: 10.1038/Sj.Bjc.6690017 |
0.355 |
|
| 1999 |
Jiang H, Granville DJ, McManus BM, Levy JG, Hunt DW. Selective depletion of a thymocyte subset in vitro with an immunomodulatory photosensitizer. Clinical Immunology (Orlando, Fla.). 91: 178-87. PMID 10227810 DOI: 10.1006/Clim.1999.4695 |
0.306 |
|
| 1999 |
King DE, Jiang H, Simkin GO, Obochi MO, Levy JG, Hunt DW. Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells. Scandinavian Journal of Immunology. 49: 184-92. PMID 10075023 DOI: 10.1046/J.1365-3083.1999.00498.X |
0.329 |
|
| 1999 |
Hunt DW, Jiang H, Granville DJ, Chan AH, Leong S, Levy JG. Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. Immunopharmacology. 41: 31-44. PMID 9950267 DOI: 10.1016/S0162-3109(98)00051-4 |
0.308 |
|
| 1998 |
Hunt DW, Levy JG. Immunomodulatory aspects of photodynamic therapy. Expert Opinion On Investigational Drugs. 7: 57-64. PMID 15991918 DOI: 10.1517/13543784.7.1.57 |
0.343 |
|
| 1998 |
Hunt DW, Jiang H, Levy JG. The porphyrin photosensitizer Photofrin elevates murine splenic erythropoiesis. Immunopharmacology and Immunotoxicology. 20: 409-20. PMID 9736445 DOI: 10.3109/08923979809034823 |
0.371 |
|
| 1998 |
Hunt DW, Jiang H, Levy JG. Photofrin increases murine spleen cell transferrin receptor expression and responsiveness to recombinant myeloid and erythroid growth factors. Immunopharmacology. 38: 267-78. PMID 9506827 DOI: 10.1016/S0162-3109(97)00086-6 |
0.434 |
|
| 1998 |
Ratkay LG, Chowdhary RK, Iamaroon A, Richter AM, Neyndorff HC, Keystone EC, Waterfield JD, Levy JG. Amelioration of antigen-induced arthritis in rabbits by induction of apoptosis of inflammatory cells with local application of transdermal photodynamic therapy. Arthritis and Rheumatism. 41: 525-34. PMID 9506581 DOI: 10.1002/1529-0131(199803)41:3<525::Aid-Art19>3.0.Co;2-I |
0.332 |
|
| 1998 |
Granville DJ, Jiang H, An MT, Levy JG, McManus BM, Hunt DW. Overexpression of Bcl-X(L) prevents caspase-3-mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD-MA. Febs Letters. 422: 151-4. PMID 9489995 DOI: 10.1016/S0014-5793(97)01616-5 |
0.316 |
|
| 1998 |
Granville DJ, Levy JG, Hunt DWC. Photodynamic Treatment with Benzoporphyrin Derivative Monoacid Ring A Produces Protein Tyrosine Phosphorylation Events and DNA Fragmentation in Murine P815 Cells Photochemistry and Photobiology. 67: 358-362. DOI: 10.1111/J.1751-1097.1998.Tb05210.X |
0.336 |
|
| 1997 |
Granville DJ, Levy JG, Hunt DW. Photodynamic therapy induces caspase-3 activation in HL-60 cells. Cell Death and Differentiation. 4: 623-8. PMID 14555976 DOI: 10.1038/Sj.Cdd.4400286 |
0.304 |
|
| 1997 |
Margaron P, Sorrenti R, Levy JG. Photodynamic therapy inhibits cell adhesion without altering integrin expression. Biochimica Et Biophysica Acta. 1359: 200-10. PMID 9434126 DOI: 10.1016/S0167-4889(97)00115-8 |
0.388 |
|
| 1997 |
Simkin GO, King DE, Levy JG, Chan AH, Hunt DW. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative. Immunopharmacology. 37: 221-30. PMID 9403341 DOI: 10.1016/S0162-3109(97)00051-9 |
0.325 |
|
| 1997 |
Hunt DW, Levy JG. Influence of Photofrin on the hematopoietic accessory function of murine peritoneal cells. Immunopharmacology and Immunotoxicology. 19: 349-65. PMID 9248863 DOI: 10.3109/08923979709046981 |
0.408 |
|
| 1996 |
Richter AM, Yip S, Meadows H, Jain AK, Neyndorff H, Moreno G, Salet C, Levy JG. Photosensitizing potencies of the structural analogues of benzoporphyrin derivative in different biological test systems Journal of Clinical Laser Medicine and Surgery. 14: 335-341. PMID 9612201 DOI: 10.1089/Clm.1996.14.335 |
0.304 |
|
| 1996 |
Leong S, Chan AH, Levy JG, Hunt DW. Transcutaneous photodynamic therapy alters the development of an adoptively transferred form of murine experimental autoimmune encephalomyelitis. Photochemistry and Photobiology. 64: 751-7. PMID 8931371 DOI: 10.1111/J.1751-1097.1996.Tb01830.X |
0.398 |
|
| 1996 |
Hunt DWC, Jiang HJ, Granville DJ, King DE, Levy JG. Monoclonal antibody LR-1 recognizes marine heat-stable antigen, a marker of antigen-presenting cells and developing hematopoietic cells International Archives of Allergy and Immunology. 111: 218-229. PMID 8917116 DOI: 10.1159/000237371 |
0.422 |
|
| 1995 |
Hunt DW, Sorrenti RA, Renke ME, Waterfield E, Levy JG. Accelerated myelopoietic recovery in irradiated mice treated with Photofrin. International Journal of Immunopharmacology. 17: 33-9. PMID 7782151 DOI: 10.1016/0192-0561(94)00078-3 |
0.382 |
|
| 1995 |
Hunt DW, Jiang HJ, Levy JG, Chan AH. Sensitivity of activated murine peritoneal macrophages to photodynamic killing with benzoporphyrin derivative. Photochemistry and Photobiology. 61: 417-21. PMID 7740088 DOI: 10.1111/J.1751-1097.1995.Tb08633.X |
0.327 |
|
| 1995 |
Obochi MO, Canaan AJ, Jain AK, Richter AM, Levy JG. Targeting activated lymphocytes with photodynamic therapy: susceptibility of mitogen-stimulated splenic lymphocytes to benzoporphyrin derivative (BPD) photosensitization. Photochemistry and Photobiology. 62: 169-75. PMID 7638262 DOI: 10.1111/J.1751-1097.1995.Tb05254.X |
0.454 |
|
| 1995 |
Levy JG, Dowding C, Mitchell D, Sorrenti R, Yip S, Jamieson C. Selective elimination of malignant stem cells using photosensitizers followed by light treatment Stem Cells. 13: 336-343. PMID 7549891 DOI: 10.1002/Stem.5530130403 |
0.342 |
|
| 1994 |
Keating A, Jamieson C, Hornby A, Wang XH, Levy J. Photodynamic elimination of clonogenic Ph+ chronic myeloid leukemia cells. Leukemia & Lymphoma. 265-9. PMID 8251908 DOI: 10.3109/10428199309047897 |
0.351 |
|
| 1994 |
Allison BA, Pritchard PH, Levy JG. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative. British Journal of Cancer. 69: 833-9. PMID 8180011 DOI: 10.1038/Bjc.1994.162 |
0.329 |
|
| 1994 |
Hunt DW, Sorrenti RA, Renke ME, Xie LY, Waterfield EM, Levy JG. Effect of porphyrins on the hematopoietic recovery of mice treated with gamma-radiation. Immunopharmacology and Immunotoxicology. 16: 55-70. PMID 8169323 DOI: 10.3109/08923979409029900 |
0.343 |
|
| 1994 |
Ratkay LG, Chowdhary RK, Neyndorff HC, Tonzetich J, Waterfield JD, Levy JG. Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant-enhanced arthritis in MRL-lpr mice. Clinical and Experimental Immunology. 95: 373-7. PMID 8137534 DOI: 10.1111/J.1365-2249.1994.Tb07006.X |
0.336 |
|
| 1994 |
Chowdhary RK, Ratkay LG, Neyndorff HC, Richter A, Obochi M, Waterfield JD, Levy JG. The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice. Clinical Immunology and Immunopathology. 72: 255-63. PMID 8050199 DOI: 10.1006/Clin.1994.1139 |
0.367 |
|
| 1994 |
Richter AM, Jain AK, Obochi M, Meadows H, Canaan AJ, Levy JG. Activation of benzoporphyrin derivative in the circulation of mice without skin photosensitivity. Photochemistry and Photobiology. 59: 350-5. PMID 8016215 DOI: 10.1111/J.1751-1097.1994.Tb05046.X |
0.399 |
|
| 1994 |
Ratkay LG, Zhang D, Tonzetich J, Levy JG, Waterfield JD. Evaluation of a model for post-partum arthritis and the role of oestrogen in prevention of MRL-lpr associated rheumatic conditions. Clinical and Experimental Immunology. 98: 52-9. PMID 7923884 DOI: 10.1111/J.1365-2249.1994.Tb06606.X |
0.327 |
|
| 1993 |
Jamieson C, Richter A, Levy JG. Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using a murine tumor model. Experimental Hematology. 21: 629-34. PMID 8513863 |
0.307 |
|
| 1993 |
Davis N, Liu D, Jain AK, Jiang SY, Jiang F, Richter A, Levy JG. Modified polyvinyl alcohol-benzoporphyrin derivative conjugates as phototoxic agents. Photochemistry and Photobiology. 57: 641-7. PMID 8506392 DOI: 10.1111/J.1751-1097.1993.Tb02930.X |
0.378 |
|
| 1993 |
Richter AM, Waterfield E, Jain AK, Canaan AJ, Allison BA, Levy JG. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochemistry and Photobiology. 57: 1000-6. PMID 8367528 DOI: 10.1111/J.1751-1097.1993.Tb02962.X |
0.321 |
|
| 1993 |
Hunt DW, Sorrenti RA, Smits CB, Levy JG. Photofrin, but not benzoporphyrin derivative, stimulates hematopoiesis in the mouse. Immunopharmacology. 26: 203-12. PMID 8288441 DOI: 10.1016/0162-3109(93)90036-P |
0.451 |
|
| 1993 |
Curry PM, Levy JG. Stress protein expression in murine tumor cells following photodynamic therapy with benzoporphyrin derivative Photochemistry and Photobiology. 58: 374-379. PMID 8234472 DOI: 10.1111/J.1751-1097.1993.Tb09577.X |
0.364 |
|
| 1993 |
Jamieson C, Hornby A, Richter A, Mitchell D, Levy J. Relative sensitivity of leukemic (CML) and normal progenitor cells to treatment with the photosensitizer benzoporphyrin derivative and light. Journal of Hematotherapy. 2: 383-386. PMID 7922000 DOI: 10.1089/Scd.1.1993.2.383 |
0.354 |
|
| 1993 |
Curry PM, Richter AM, Jain AK, Levy JG. Intracellular events associated with uptake of a monomeric photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), and its subsequent activation with light Proceedings of Spie. 1881: 262-274. DOI: 10.1117/12.146318 |
0.408 |
|
| 1992 |
Richter AM, Jain AK, Canaan AJ, Waterfield E, Sternberg ED, Levy JG. Photosensitizing efficiency of two regioisomers of the benzoporphyrin derivative monoacid ring A (BPD-MA). Biochemical Pharmacology. 43: 2349-58. PMID 1610400 DOI: 10.1016/0006-2952(92)90313-8 |
0.305 |
|
| 1992 |
Jiang FN, Allison B, Liu D, Levy JG. Enhanced photodynamic killing of target cells by either monoclonal antibody or low density lipoprotein mediated delivery systems Journal of Controlled Release. 19: 41-58. DOI: 10.1016/0168-3659(92)90064-X |
0.382 |
|
| 1991 |
Shellard JE, Leitch HA, Logan PM, McMaster WR, Levy JG. Purification of an in vitro inhibitor of normal myelopoiesis using a monoclonal antibody directed to a common antigen of myelogenous leukemia (CAMAL). Experimental Hematology. 19: 136-42. PMID 1991495 |
0.311 |
|
| 1991 |
Richter AM, Waterfield E, Jain AK, Allison B, Sternberg ED, Dolphin D, Levy JG. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model. British Journal of Cancer. 63: 87-93. PMID 1989669 DOI: 10.1038/Bjc.1991.18 |
0.386 |
|
| 1991 |
Jiang FN, Liu DJ, Neyndorff H, Chester M, Jiang SY, Levy JG. Photodynamic killing of human squamous cell carcinoma cells using a monoclonal antibody-photosensitizer conjugate. Journal of the National Cancer Institute. 83: 1218-25. PMID 1870147 DOI: 10.1093/Jnci/83.17.1218 |
0.387 |
|
| 1991 |
Richter AM, Yip S, Waterfield E, Logan PM, Slonecker CE, Levy JG. Mouse skin photosensitization with benzoporphyrin derivatives and Photofrin: macroscopic and microscopic evaluation. Photochemistry and Photobiology. 53: 281-6. PMID 1826372 DOI: 10.1111/J.1751-1097.1991.Tb03935.X |
0.328 |
|
| 1991 |
Allison BA, Waterfield E, Richter AM, Levy JG. The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochemistry and Photobiology. 54: 709-15. PMID 1798748 DOI: 10.1111/J.1751-1097.1991.Tb02079.X |
0.352 |
|
| 1990 |
Jamieson CH, McDonald WN, Levy JG. Preferential uptake of benzoporphyrin derivative by leukemic versus normal cells. Leukemia Research. 14: 209-19. PMID 2319804 DOI: 10.1016/0145-2126(90)90128-V |
0.35 |
|
| 1990 |
Richter AM, Waterfield E, Jain AK, Sternberg ED, Dolphin D, Levy JG. In vitro evaluation of phototoxic properties of four structurally related benzoporphyrin derivatives. Photochemistry and Photobiology. 52: 495-500. PMID 2284343 DOI: 10.1111/J.1751-1097.1990.Tb01791.X |
0.32 |
|
| 1990 |
Jiang FN, Jiang S, Liu D, Richter A, Levy JG. Development of technology for linking photosensitizers to a model monoclonal antibody. Journal of Immunological Methods. 134: 139-49. PMID 2230147 DOI: 10.1016/0022-1759(90)90122-C |
0.307 |
|
| 1990 |
Yee GK, Levy JG, Kripke ML, Ullrich SE. The role of suppressor factors in the regulation of immune responses by ultraviolet radiation-induced suppressor T lymphocytes. III. Isolation of a suppressor factor with the B16G monoclonal antibody Cellular Immunology. 126: 255-267. PMID 2138059 DOI: 10.1016/0008-8749(90)90319-M |
0.384 |
|
| 1990 |
Richter AM, Cerruti-Sola S, Sternberg ED, Dolphin D, Levy JG. Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice. Journal of Photochemistry and Photobiology. B, Biology. 5: 231-44. PMID 2111398 DOI: 10.1016/1011-1344(90)80008-L |
0.312 |
|
| 1989 |
Deal H, Steele JK, Stammers AT, Singhai R, Levy JG. Preadministration of a T-suppressor factor enhances tumor immunity in DBA/2 mice. Cancer Immunology, Immunotherapy : Cii. 28: 193-8. PMID 2493988 DOI: 10.1007/Bf00204988 |
0.383 |
|
| 1989 |
Steele JK, Levy JG, Waterfield JD. Isolation and characterization of a T-suppressor factor specific for the lupus-associated autoantigen RNP-Sm. Autoimmunity. 3: 17-28. PMID 2491618 DOI: 10.3109/08916938909043610 |
0.324 |
|
| 1988 |
Logan PM, Whitney S, Naiman S, Levy JG. CAMAL: a new prognostic marker for remission in acute nonlymphoblastic leukemia. Leukemia Research. 12: 19-24. PMID 3282127 DOI: 10.1016/S0145-2126(98)80004-0 |
0.31 |
|
| 1988 |
Shipman RC, Levy JG. Expression of a leukemia-associated antigen (CAMAL) in four myeloid leukemia cell lines. Leukemia Research. 12: 537-43. PMID 3172816 DOI: 10.1016/0145-2126(88)90082-3 |
0.373 |
|
| 1988 |
Steele JK, Liu D, Stammers AT, Whitney S, Levy JG. Suppressor deletion therapy: selective elimination of T suppressor cells in vivo using a hematoporphyrin conjugated monoclonal antibody permits animals to reject syngeneic tumor cells. Cancer Immunology, Immunotherapy : Cii. 26: 125-31. PMID 2965972 DOI: 10.1007/Bf00205605 |
0.478 |
|
| 1987 |
Singhai R, Levy JG. Isolation of a T-cell clone that reacts with both antigen and anti-idiotype: evidence for anti-idiotype as internal image for antigen at the T-cell level. Proceedings of the National Academy of Sciences of the United States of America. 84: 3836-40. PMID 3495798 DOI: 10.1073/Pnas.84.11.3836 |
0.408 |
|
| 1987 |
Liu D, Purssell R, Levy JG. Production and characterization of high affinity monoclonal antibodies to cyclic anti-depressant molecules. Journal of Toxicology. Clinical Toxicology. 25: 527-38. PMID 3446821 DOI: 10.3109/15563658708992655 |
0.36 |
|
| 1987 |
Waterfield JD, Fairhurst M, Chu R, Levy JG. Antigen-specific T-cell hyporesponsiveness in MRL congenic mice can be explained by two independent cellular defects. Immunology. 61: 173-8. PMID 2954899 |
0.309 |
|
| 1987 |
Steele JK, Kawasaki H, Kuchroo VK, Minami M, Levy JG, Dorf ME. A monoclonal antibody raised to tumor-specific T cell-derived suppressor factors also recognizes T suppressor inducer factors of the 4-hydroxy-3-nitrophenyl acetyl hapten suppressor network. Journal of Immunology (Baltimore, Md. : 1950). 139: 2629-34. PMID 2443567 |
0.304 |
|
| 1986 |
Steele JK, Stammers AT, Levy JG, Waterfield JD. Isolation of functional polyclonal TsF from MRL-lpr spleens using monoclonal antibody absorbance. Cellular Immunology. 102: 386-94. PMID 2948665 DOI: 10.1016/0008-8749(86)90432-6 |
0.429 |
|
| 1985 |
Mew D, Lum V, Wat CK, Towers GH, Sun CH, Walter RJ, Wright W, Berns MW, Levy JG. Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selected cell lines subsequent to light activation. Cancer Research. 45: 4380-6. PMID 4028022 |
0.312 |
|
| 1985 |
Levy JG, Logan PM, Whitney S, Malcolm AJ, Naiman S, Powles R, Crawford D. Demonstration of a leukemia-associated antigen (CAMAL) in peripheral blood leucocytes of bone marrow transplant patients prior to relapse. Transplantation. 40: 167-73. PMID 3895623 DOI: 10.1097/00007890-198508000-00012 |
0.326 |
|
| 1985 |
Singhai R, Hoffmann GW, Levy JG. Abrogation and reconstitution of nonresponsiveness: a correlation with high network connectivity. European Journal of Immunology. 15: 526-9. PMID 3158533 DOI: 10.1002/Eji.1830150519 |
0.356 |
|
| 1985 |
Steele JK, Stammers AT, Chan A, Maier T, Levy JG. Preliminary characterization of a soluble immunosuppressive molecule from DBA/2 spleen cells using monoclonal antibody immunoadsorbence. Cellular Immunology. 90: 303-13. PMID 3155655 DOI: 10.1016/0008-8749(85)90195-9 |
0.369 |
|
| 1985 |
Buchan AMJ, Sikora LKJ, Levy JG, McIntosh CHS, Dyck I, Brown JC. An immunocytochemical investigation with monoclonal antibodies to somatostatin Histochemistry. 83: 175-180. PMID 2864326 DOI: 10.1007/Bf00495150 |
0.369 |
|
| 1984 |
Malcolm AJ, Shipman RC, Logan PM, Levy JG. A monoclonal antibody to myelogenous leukemia: isolation and characterization. Experimental Hematology. 12: 539-47. PMID 6589167 |
0.311 |
|
| 1984 |
Sikora LKJ, Buchan AMJ, Levy JG, McIntosh CHS, Brown JC. VIP-innervation of rat intestine: A developmental study with monoclonal antibodies Peptides. 5: 231-237. PMID 6473154 DOI: 10.1016/0196-9781(84)90212-2 |
0.312 |
|
| 1983 |
Shipman R, Malcolm A, Levy JG. Partial characterization of a membrane antigen which exhibits specificity for cells of patients with acute myelogenous leukaemia British Journal of Cancer. 47: 849-852. PMID 6190494 DOI: 10.1038/Bjc.1983.140 |
0.329 |
|
| 1983 |
Weaver M, Singhai R, Sikora L, Levy JG. Identification of an idiotypic marker of a major regulatory T cell of the immune response in B10.BR mice to ferredoxin. The relationship of idiotypic regulation to conventional hapten-carrier effects. Journal of Experimental Medicine. 157: 285-300. PMID 6184440 DOI: 10.1084/Jem.157.1.285 |
0.395 |
|
| 1983 |
Malcolm A, Logan P, Shipman R, Kurth R, Levy J. Analysis of human myelogenous leukemia cells in the fluorescence- activated cell sorter using a tumor-specific antiserum Blood. 61: 858-866. DOI: 10.1182/Blood.V61.5.858.Bloodjournal615858 |
0.391 |
|
| 1982 |
Maier T, Levy JG. Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor. Cancer Immunology, Immunotherapy. 13: 134-139. PMID 6819080 DOI: 10.1007/Bf00205314 |
0.432 |
|
| 1982 |
Sikora L, Weaver M, Levy JG. The use of unideterminant fragments of ferredoxin in the genetic mapping of determinant specificity of the immune response Molecular Immunology. 19: 693-703. PMID 6180312 DOI: 10.1016/0161-5890(82)90371-6 |
0.343 |
|
| 1982 |
Weaver MS, Sikora L, Levy JG. The immune response to ferredoxin: characterization of a major idiotype in serum using monoclonal antibody derived by cell fusion. Molecular Immunology. 19: 105-117. PMID 6176853 DOI: 10.1016/0161-5890(82)90252-8 |
0.367 |
|
| 1981 |
Fulton AM, Levy JG. The induction of nonspecific T suppressor lymphocytes by prostaglandin E1 Cellular Immunology. 59: 54-60. PMID 6452226 DOI: 10.1016/0008-8749(81)90433-0 |
0.397 |
|
| 1981 |
Maier T, Kilburn DG, Levy JG. Properties of syngeneic and allogeneic antisera raised to tumor-specific suppressor factor from DBA/2J mice Cancer Immunology, Immunotherapy. 12: 49-56. DOI: 10.1007/Bf00200312 |
0.415 |
|
| 1981 |
Kelly BS, Stredulinsky U, Hoek JV, Levy JG. Antibodies in the sera of patients with bronchogenic carcinoma that react with antigen from a tumour cell line Cancer Immunology, Immunotherapy. 12: 5-10. DOI: 10.1007/Bf00200306 |
0.343 |
|
| 1980 |
Al-Rammahy AK, Levy JG. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target Cellular Immunology. 56: 338-346. PMID 6781763 DOI: 10.1016/0008-8749(80)90109-4 |
0.413 |
|
| 1980 |
Fulton AM, Levy JG. Inhibition of murine tumor growth and prostaglandin synthesis by indomethacin. International Journal of Cancer. 26: 669-673. PMID 6453846 DOI: 10.1002/Ijc.2910260520 |
0.322 |
|
| 1980 |
Maier T, Levy JG, Kilburn DG. The Lyt phenotype of cells involved in the cytotoxic response to syngeneic tumor and of tumor-specific suppressor cells Cellular Immunology. 56: 392-399. PMID 6451300 DOI: 10.1016/0008-8749(80)90115-X |
0.65 |
|
| 1980 |
Fulton AM, Levy JG. The possible role of prostaglandins in mediating immune suppression by nonspecific T suppressor cells. Cellular Immunology. 52: 29-37. PMID 6446407 DOI: 10.1016/0008-8749(80)90397-4 |
0.393 |
|
| 1980 |
Al-Rammahy AK, Shipman S, Jackson A, Malcolm A, Levy JG. Evidence for a common leukemia-associated antigen in acute myelogenous leukemia Cancer Immunology, Immunotherapy. 9: 181-185. DOI: 10.1007/Bf00205623 |
0.373 |
|
| 1979 |
Al-Rammahy AK, Levy JG, Kelly B. Characterization of immunologically active peptides from the cell wall of T. mentagrophytes. Mycopathologia. 66: 139-146. PMID 440400 DOI: 10.1007/Bf00683962 |
0.332 |
|
| 1979 |
Al-Rammahy AK, Levy JG, Kelly B. Isolation and partial characterization of immunologically reactive fractions from chitinase digested cell wall of Trichophyton mentagrophytes. Mycopathologia. 66: 129-137. PMID 440399 DOI: 10.1007/Bf00683961 |
0.33 |
|
| 1979 |
Al-Rammahy A, Levy JG. The preparation of xenoantiserum specific for a murine mastocytoma cell line. Cancer Immunology, Immunotherapy. 6: 163-167. DOI: 10.1007/Bf00205541 |
0.458 |
|
| 1978 |
Whitney RB, Kelly BS, Levy JG. Immunosuppression in mice bearing primary tumors. European Journal of Cancer. 14: 699-705. PMID 658094 DOI: 10.1016/0014-2964(78)90306-7 |
0.426 |
|
| 1978 |
Takei F, Levy JG, Kilburn DG. Effect of adult thymectomy on tumour immunity in mice. British Journal of Cancer. 37: 723-31. PMID 306831 DOI: 10.1038/Bjc.1978.110 |
0.709 |
|
| 1978 |
Gasocyne RD, Whitney RB, Levy JG. Recovery of immune competence after tumour resection in mice: correlation with loss of suppressor elements. British Journal of Cancer. 37: 190-8. PMID 305254 DOI: 10.1038/bjc.1978.27 |
0.312 |
|
| 1977 |
Whitney RB, Pope BL, Levy JG. Immune competence and immunosuppressive factors in splenectomized tumor-bearing mice. Cellular Immunology. 28: 15-21. PMID 832312 DOI: 10.1016/S0008-8749(77)80002-6 |
0.34 |
|
| 1977 |
Acres RB, Levy JG. The influence of allogeneic or syngeneic cell surface backgrounds on the antibody response of mice to rabbit Fab' fragments. Cellular Immunology. 31: 216-224. PMID 326421 DOI: 10.1016/0008-8749(77)90023-5 |
0.457 |
|
| 1976 |
Whitney RB, Levy JG. Mode of action of immunosuppressive substances in sera of tumor-bearing mice. Journal of the National Cancer Institute. 55: 1447-52. PMID 1206763 DOI: 10.1093/JNCI/55.6.1447 |
0.362 |
|
| 1976 |
Pearson T, Levy J, Kilburn D, Fairhurst K. The effect of antigen suicide on numbers of cells binding defined antigenic determinants. Journal of Immunological Methods. 10: 99-104. PMID 58940 DOI: 10.1016/0022-1759(76)90160-5 |
0.341 |
|
| 1975 |
Pearson T, Levy J, Kilburn D. The effect of specific cell inactivation on the cellular immune response to ferreodoxin peptides European Journal of Immunology. 5: 65-69. PMID 1086216 DOI: 10.1002/Eji.1830050114 |
0.426 |
|
| 1975 |
Whitney RB, Levy JG, Smith AG. Studies on the effector cell of anti-tumour immunity in a chemically induced mouse tumour system. British Journal of Cancer. 31: 157-163. PMID 1080668 DOI: 10.1038/Bjc.1975.20 |
0.435 |
|
| 1974 |
Kelly B, Kaye B, Yoshizawa W, Levy JG, Kilburn DG. Selective binding of chemically defined antigenic peptides to mouse lymphocytes. European Journal of Immunology. 4: 356-360. PMID 4854219 DOI: 10.1002/Eji.1830040510 |
0.455 |
|
| 1974 |
Whitney RB, Levy JG, Smith AG. Influence of Tumor Size and Surgical Resection on Cell-Mediated Immunity in Mice Journal of the National Cancer Institute. 53: 111-116. PMID 4835101 DOI: 10.1093/Jnci/53.1.111 |
0.362 |
|
| 1974 |
Whitney RB, Levy JG. Suppression of mitogen responses by serum from tumour-bearing mice European Journal of Cancer (1965). 10: 739-745. PMID 4469498 DOI: 10.1016/0014-2964(74)90113-3 |
0.401 |
|
| 1974 |
Levy JG, Whitney RB, Smith AG, Panno L. The relationship of immune status to the efficacy of immunotherapy in preventing tumour recurrence in mice. British Journal of Cancer. 30: 289-296. PMID 4447774 DOI: 10.1038/Bjc.1974.195 |
0.321 |
|
| 1973 |
Kelly B, Levy JG, Hull D. Cellular and humoral immune responses in guinea pigs and rabbits to chemically defined synthetic peptides. European Journal of Immunology. 3: 574-579. PMID 4766957 DOI: 10.1002/Eji.1830030910 |
0.33 |
|
| 1972 |
Waterfield D, Levy JG, Kilburn DG, Teather RM. The effect of haptenic peptides from performic acid oxidized ferredoxin from Clostridium pasteurianum and protein carrier-hapten conjugates on the immune response of macrophages and lymphoid cells from animals immunized against oxidized ferredoxin Cellular Immunology. 3: 253-263. PMID 5011012 DOI: 10.1016/0008-8749(72)90164-5 |
0.573 |
|
| 1972 |
Levy JG, Hull D, Kelly B, Kilburn DG, Teather RM. The cellular immune response to synthetic peptides containing sequences known to be haptenic in performic acid-oxidized ferredoxin from Clostridium pasteurianum Cellular Immunology. 5: 87-97. PMID 4115688 DOI: 10.1016/0008-8749(72)90086-X |
0.544 |
|
| Show low-probability matches. |
